Electroencephalogram in the intensive care unit: a focused look at acute brain injury
- PMID: 35997792
- PMCID: PMC10008537
- DOI: 10.1007/s00134-022-06854-3
Electroencephalogram in the intensive care unit: a focused look at acute brain injury
Abstract
Over the past decades, electroencephalography (EEG) has become a widely applied and highly sophisticated brain monitoring tool in a variety of intensive care unit (ICU) settings. The most common indication for EEG monitoring currently is the management of refractory status epilepticus. In addition, a number of studies have associated frequent seizures, including nonconvulsive status epilepticus (NCSE), with worsening secondary brain injury and with worse outcomes. With the widespread utilization of EEG (spot and continuous EEG), rhythmic and periodic patterns that do not fulfill strict seizure criteria have been identified, epidemiologically quantified, and linked to pathophysiological events across a wide spectrum of critical and acute illnesses, including acute brain injury. Increasingly, EEG is not just qualitatively described, but also quantitatively analyzed together with other modalities to generate innovative measurements with possible clinical relevance. In this review, we discuss the current knowledge and emerging applications of EEG in the ICU, including seizure detection, ischemia monitoring, detection of cortical spreading depolarizations, assessment of consciousness and prognostication. We also review some technical aspects and challenges of using EEG in the ICU including the logistics of setting up ICU EEG monitoring in resource-limited settings.
Keywords: Cortical spreading depolarization; Disorders of consciousness; Electroencephalogram; Intensive care unit; Ischemia; Nonconvulsive seizures; Status epilepticus.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Conflict of interest
AA, BA, and SE report no disclosures. BF is supported by grant funding from the DOD (JW200215 and W81XWH1920013). He received additional support for research through the NIH/NINDS, NIH/NIBIB, and NSF. He receives speaking fees and consulting fees from UCB Pharma, and serves on the scientific advisory boards of Marinus, Inc and Sage Therapeutics. NG reports no disclosures. EJG is supported by grant funding from the NIH R01NS117904–01, is a consultant for UCB and co-founder (no financial relationship) of Intracranial Bioanalytics (IBA). LJH has received consultation fees for advising from Accure, Aquestive, Ceribell, Eisai, Marinus, Medtronic, Neurelis, Neuropace and UCB; royalties from Wolters-Kluwer for authoring chapters for UpToDate-Neurology, and from Wiley for co-authoring the book “Atlas of EEG in Critical Care”; and honoraria for speaking or running webinars from Neuropace, Natus, and UCB. PK reports no disclosures. VL reports no disclosures. JK is supported by grant funding through the University of Calgary, Office of Health and Medical Education Scholarship. PV is supported by grants from NIH and the State of California PV has received compensation for consultancy and speaker fees and expenses from Ceribell and consultancy and speaker fees from UCB Pharma. SFZ is supported by grant funding from the NIH K23NS114201 and the American Epilepsy Society (Infrastructure grant). She is a clinical neurophysiologist for Corticare. BR reports no disclosures. JC is a minority shareholder at iCE Neurosystems.
Figures












References
-
- Herman ST, Abend NS, Bleck TP, Chapman KE, Drislane FW, Emerson RG et al. (2015) Consensus statement on continuous EEG in critically ill adults and children, part II: personnel, technical specifications, and clinical practice. J Clin Neurophysiol 32(2):96–108. 10.1097/wnp.0000000000000165 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous